Sperm Video Recording Protocol
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of this study is to obtain anonymous video clips of male semen at high magnification, to manually select out of the video spermatozoon images, and to manually classify their morphology by qualified embryologists based on the WHO Manual criteria in order to train the BAIBYS™ Fertility System. The study will enroll males attending the clinic who may elect to contribute their unused excess sample materials from semen analysis or IVF/ICSI (Intracytoplasmic sperm injection) which is a technique used during in vitro fertilization (IVF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2023
CompletedFirst Posted
Study publicly available on registry
November 29, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedJuly 23, 2024
July 1, 2024
8 months
November 21, 2023
July 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Obtaining 6,000 classified sperm images
Obtaining 6,000 sperm images classified each by at least 2 embryologist based on the WHO 6th edition criteria to add to the AI training of the Baibys system.
Each semen sample will be recorded for 10 minutes
Eligibility Criteria
The study will enroll 30-40 male subjects attending the clinic and willing to contribute their unused excess sample materials from semen analysis or IVF/ICSI. Enrollment will include three sub-populations of at least 15 patients to ensure diversity \[characteristics of ethnic and racial diversity, BMI diversity, and normal (\> WHO 5%ile cutoffs) versus abnormal morphology\].
You may qualify if:
- Assigned male at birth and possessing typical male anatomy (i.e., one or two testicles and penis)
- Scheduled to produce a semen sample for fertility evaluation
- Able to produce a semen sample, including, in the judgement of the PI, ability to follow instructions provided in English by the physician or physician's team members
- At least a 10th grade education level, to be able to read and understand the ICF; evaluated by either completion of 10th grade, or by any higher level of education or GED
- Age 22 or older at the time of consent
You may not qualify if:
- Known azoospermia prior to semen analysis.
- Subjects with azoospermia or otherwise inadequate sample discovered during the trial will be compensated for their participation in recognition of their efforts to contribute to science, but will be replaced with an additional subject for the data collection and labeling to reach a total sample of up to 40 videos
- History of chemotherapy or radiation within prior 12 months, due to increased chance of azoospermia
- Developmental delays or other neurological impairment that could impair ability to freely consent, as evaluated by the PI
- Any reason why in the sole judgement of the PI, consent to participate cannot be freely given
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BAIBYS Fertilitylead
Study Sites (1)
CCRM Northern Virginia
Vienna, Virginia, 22182, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Carter Owen, M.D.
CCRM Fertility Clinic and IVF Clinic
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2023
First Posted
November 29, 2023
Study Start
December 1, 2023
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
July 23, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- 12 months after follow up pivotal trial is completed
- Access Criteria
- The IPD will be anonymized and shared as described in the plan. All those getting access will not be able to de-identify any patient's data. Anonymized patient's data including selection of sperm images/videos will be used together with the clinical study report and protocol will be shared to the medical writer and the supervisor author for the purpose of the the final publication.
Anonymized patient's data including selection of sperm images/videos will be used together with the clinical study report and protocol will be shared to the medical writer and the supervisor author for the purpose of the the final publication.